Table 1.
H2S donors | Structures | H2S release mechanism |
Representative bioactivities |
Key ref. |
---|---|---|---|---|
H2S (gas) | H2S | Authentic H2S resource | Hibernation induction Type II diabetes amelioration | 67–70 |
Sulfide salts | NaHS & Na2S | Hydrolysis | Heart failure reduction Anti-inflammation | 75–83 |
Garlic-derived sulfur compounds | R-S-Sn-S-R | Thiol activation | Vasodilation | 86 |
Lawesson’s reagent | Hydrolysis | Anti-inflammation Ion channel regulation | 97, 98 | |
GYY4137 | Hydrolysis | Vasodilation Anti-inflammation Anti-cancer | 99, 105, 106 | |
Phosphorodithioates | Hydrolysis | Prevention against oxidative damages | 107 | |
DTTs | Hydrolysis | Anti-inflammation Anti-cancer | 114, 124–126, 129 | |
N-(acylthio)-benzamides | Thiol activation | No biological effects were reported to date. | 132 | |
S-SH compounds | Thiol activation | MI/R protection | 133 | |
Dithioperoxyanhydrides | Thiol activation | Vasodilation | 137 | |
Arylthioamides | Thiol activation | Vasodilation | 140 | |
Gem-dithiol compounds | Light activation | No biological effects were reported to date. | 141 | |
Ketoprofenate-caged compound | Light activation | No biological effects were reported to date. | 149 | |
Thioamino acids | Bicarbonate activation | Vasodilation | 150 |